Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-16

Clinical Trial Update: Changes in Salivary Asprosin, IL-39, IL-40 and IL-1β Levels in Diabetic Patients with Periodontitis [NA]

View source ↗

Summary

A clinical trial investigating changes in salivary biomarker levels (asprosin, IL-39, IL-40, and IL-1β) in diabetic patients with periodontitis. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Necmettin Erbakan University | Conditions: Diabetes Mellitus, Periodontal Disease | NA | Status: NOT_YET_RECRUITING